I assume typo too. Or the next quarter meaning next 3 months. September was mentioned in the previous webinar for NATA approval but as they say substantial progress has been made and nearing completion.
Pathology lab agreements would be very nice but even at 100,000 test in North Ryde compelling numbers for an initial first year. Im sure they wont be stopping there tho.
Like a duck, composed on the surface but legs going hard in the background.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-7
Add BDX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.86M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.3¢ | 9.9¢ | $200.2K | 2.003M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 954738 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 343815 | 2 |
View Market Depth
| Last trade - 15.45pm 11/11/2024 (20 minute delay) ? |
| BDX (ASX) Chart |